Panu M Jaakkola (Panu Jaakkola)

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Venues

Cancers

The Journal of biological chemistry

Clinical cancer research : an official journal of the American Association for Cancer Research

University of Helsinki

Turun yliopisto lääketieteellinen tiedekunta (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki Jan 01 2018

Finland

Professor :: Clinicum

Helsinki University Central Hospital Jan 01 2018

Finland

Research director :: Comprehensive cancer center

Turun yliopisto lääketieteellinen tiedekunta Jan 01 2014 - Dec 31 2017

Finland

Lecturer

Turku University Hospital May 01 2013 - Dec 31 2017

Finland

Consultant :: Oncology and radiotherapy

Education History

Turun yliopisto lääketieteellinen tiedekunta May 20 1998

Finland

PHD

Publications

Saana Virtanen, Heidi Pihlman, Maria Silvoniemi, Pia P Vihinen, Panu M Jaakkola, Kalle E Mattila
Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study. Cancers 16 (4) (2024)
Saana Virtanen, Heidi Pihlman, Maria Silvoniemi, Pia P Vihinen, Panu M Jaakkola, Kalle E Mattila
Reasons for Treatment Discontinuation and Their Effect on Outcomes of Immunotherapy in Southwest Finland: A Retrospective, Real-World Cohort Study. Cancers 16 (4) (2024)
Kalle E Mattila, Paula Vainio, Panu M Jaakkola
Prognostic Factors for Localized Clear Cell Renal Cell Carcinoma and Their Application in Adjuvant Therapy. Cancers 14 (1) (2022)
Reetta Virtakoivu, Jenna H Rannikko, Miro Viitala, Felix C Vaura, Akira Takeda, Tapio Lönnberg, Jussi Koivunen, Panu M Jaakkola, Annika Pasanen, Shishir Shetty, Maja J A de Jonge, Debbie G J Robbrecht, Yuk Ting Ma, Tanja Skyttä, Anna R Minchom, Sirpa Jalkanen, Matti K Karvonen, Jami Mandelin, Petri Bono, Maija Hollmén
Systemic Blockade of Clever-1 Elicits Lymphocyte Activation Alongside Checkpoint Molecule Downregulation in Patients with Solid Tumors: Results from a Phase I/II Clinical Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Petra Miikkulainen, Heidi Högel, Fatemeh Seyednasrollah, Krista Rantanen, Laura L Elo, Panu M Jaakkola
Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma. The Journal of biological chemistry 294 (10) (2019)

Panu M Jaakkola.css-eqlu8i{font-size:small;padding-left:4px;} (Panu Jaakkola)

Publication Activity (10 Years)

Top Topics

Top Venues

Panu M Jaakkola (Panu Jaakkola)